Vimta Labs informs about rectified audited financial results

09 May 2017 Evaluate

Vimta Labs has informed about submission of the rectified Audited Financial Results for the 4th Quarter & for the Financial year ended March 31, 2017 in Schedule III format and Auditors Report with unmodified opinion along with declaration in respect thereof. 

The above information is a part of company’s filings submitted to BSE.

Vimta Labs Share Price

545.85 -12.85 (-2.30%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.